Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)
Trademark/Service Mark Application, Principal Register
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a series of undulating dots in varying sizes stemming from the "i" in the literal element Emgality.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
750 x 466
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Eli Lilly and Company
*STREET
Lilly Corporate Center
*CITY
Indianapolis
*STATE
(Required for U.S. applicants)
Indiana
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
46285
PHONE
317 651 1346
FAX
317 276 1919
EMAIL ADDRESS
XXXX
WEBSITE ADDRESS
www.lilly.com
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Indiana
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic
dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders,
cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia,
inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders,
migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis,
Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic
preparations for use in the diagnosis of neurodegenerative diseases
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
Medical information services in the field of central nervous systems diseases and disorders
FILING BASIS
SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT
The literal element is a coined, non-dictionary word with no English translation.
ATTORNEY INFORMATION
NAME
Bruce W. Longbottom
FIRM NAME
Eli Lilly and Company
STREET
Lilly Corporate Center
CITY
Indianapolis
STATE
Indiana
COUNTRY
United States
ZIP/POSTAL CODE
46285
PHONE
317 651 1346
FAX
317 276 1919
EMAIL ADDRESS
trademarks@lilly.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
OTHER APPOINTED ATTORNEY
John R. Rudolph, Sheldon Pontaoe, Douglas K. Norman, Steven P. Caltrider, Gilbert T. Voy
CORRESPONDENCE INFORMATION
NAME
Bruce W. Longbottom
FIRM NAME
Eli Lilly and Company
STREET
Lilly Corporate Center
CITY
Indianapolis
STATE
Indiana
COUNTRY
United States
ZIP/POSTAL CODE
46285
PHONE
317 651 1346
FAX
317 276 1919
*EMAIL ADDRESS
trademarks@lilly.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
550
*TOTAL FEE PAID
550
SIGNATURE INFORMATION
SIGNATURE
/blongbottom/
SIGNATORY'S NAME
Bruce W. Longbottom
SIGNATORY'S POSITION
Assistant General Counsel
SIGNATORY'S PHONE NUMBER
317 651 1346
DATE SIGNED
05/03/2017
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)
Trademark/Service Mark Application, Principal Register
Serial Number:87435081
Filing Date:05/03/2017
To the Commissioner for Trademarks:
MARK: Emgality (stylized and/or with design, see mark)
The literal element of the mark consists of Emgality.
The applicant is not claiming color as a feature of the mark. The mark consists of a series of undulating dots in varying sizes stemming from the "i" in the literal element Emgality.
The applicant, Eli Lilly and Company, a corporation of Indiana, having an address of
Lilly Corporate Center
Indianapolis, Indiana 46285
United States
317 651 1346(phone)
317 276 1919(fax)
XXXX (not authorized)
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders,
atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and
disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders,
hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and
disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid
arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical
diagnostic preparations for use in the diagnosis of neurodegenerative diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: Medical information services in the field of central nervous systems diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Miscellaneous Statement
The literal element is a coined, non-dictionary word with no English translation.
For informational purposes only, applicant's website address is: www.lilly.com
The applicant's current Attorney Information:
Bruce W. Longbottom and John R. Rudolph, Sheldon Pontaoe, Douglas K. Norman, Steven P. Caltrider, Gilbert T. Voy of Eli Lilly and
Company Lilly Corporate Center
Indianapolis, Indiana 46285
United States
317 651 1346(phone)
317 276 1919(fax)
trademarks@lilly.com (authorized)
The applicant's current Correspondence Information:
Bruce W. Longbottom
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285
317 651 1346(phone)
317 276 1919(fax)
trademarks@lilly.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /blongbottom/ Date: 05/03/2017
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Assistant General Counsel
Payment Sale Number: 87435081
Payment Accounting Date: 05/04/2017
Serial Number: 87435081
Internet Transmission Date: Wed May 03 14:37:30 EDT 2017
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-201705031437304
74368-87435081-5906acc697438b3d5675acf22
4eeb770e21d939dbdf6c5bafed8593ca8263e36c
-DA-921-20170503103815426833